Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
38
MCS Quote, Financials, Valuation and Earnings
Last price:
$17.24
Seasonality move
:
1.22%
Day range:
$16.98 - $17.31
52-week range:
$11.38 - $23.16
Dividend yield:
2.04%
P/E ratio:
54.63x
P/S ratio:
0.73x
P/B ratio:
1.22x
Volume:
200.5K
Avg. volume:
176K
1-year change:
47.86%
Market cap:
$538M
Revenue:
$735.6M
EPS (TTM):
-$0.42
Analysts' Opinion
-
Consensus RatingMarcus has received a consensus rating of Buy. The company's average rating is a Buy based on 3 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $24.67, Marcus has an estimated upside of 43.49% from its current price of $17.24.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $24.00 representing -39.62% downside risk from its current price of $17.24.
Fair Value
-
According to the consensus of 3 analysts, Marcus has 43.49% upside to fair value with a price target of $24.67 per share.
MCS vs. S&P 500
-
Over the past 5 trading days, Marcus has overperformed the S&P 500 by 0.29% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Marcus does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Marcus has grown year-over-year revenues for 3 quarters straight. In the most recent quarter Marcus reported revenues of $148.8M.
Earnings Growth
-
Marcus has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Marcus reported earnings per share of -$0.54.
Enterprise value:
725M
EV / Invested capital:
--
Price / LTM sales:
0.73x
EV / EBIT:
842.26x
EV / Revenue:
0.97x
PEG ratio (5yr expected):
-0.05x
EV / Free cash flow:
-236.48x
Price / Operating cash flow:
6.44x
Enterprise value / EBITDA:
11.00x
Gross Profit (TTM):
$288.4M
Return On Assets:
-1.23%
Net Income Margin (TTM):
-1.71%
Return On Equity:
-2.8%
Return On Invested Capital:
-2.02%
Operating Margin:
-14.64%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $697.4M | $715.8M | $745.8M | $138.5M | $148.8M | |
| Gross Profit | $265.8M | $279.7M | $288.4M | $46.2M | $47.3M | |
| Operating Income | $18M | $26.9M | $17.9M | -$16.6M | -$21.8M | |
| EBITDA | $87.1M | $94.4M | $65.9M | -$686K | -$3.5M | |
| Diluted EPS | -$0.27 | $0.24 | -$0.42 | -$0.38 | -$0.54 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $63.7M | $64.7M | $52.9M | $61.5M | $59.8M | |
| Total Assets | $1.2B | $1.1B | $1B | $1B | $1B | |
| Current Liabilities | $210.6M | $186.4M | $140.1M | $141.9M | $142.8M | |
| Total Liabilities | $768M | $697.5M | $593.3M | $558.8M | $576.2M | |
| Total Equity | $457.9M | $441.8M | $448.4M | $459.3M | $441.8M | |
| Total Debt | $322.4M | $261.5M | $189.3M | $169.8M | $198.9M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $79M | $95.3M | $83.7M | -$15.1M | -$35.3M | |
| Cash From Investing | -$6.8M | -$48M | -$83.9M | -$20.8M | -$22.8M | |
| Cash From Financing | -$83.7M | -$39.6M | -$4.6M | -$3.4M | $29.3M | |
| Free Cash Flow | $39.8M | $50M | -$3.1M | -$30.5M | -$58.3M | |
MCS
Sector
Market Cap
$538M
$85.7M
Price % of 52-Week High
74.22%
71.43%
Dividend Yield
2.04%
0%
Shareholder Yield
3.88%
3.73%
1-Year Price Total Return
49.22%
-9.01%
Beta (5-Year)
1.239
0.572
Dividend yield:
2.04%
Annualized payout:
$0.28
Payout ratio:
-68.74%
Growth streak:
2 years
Technicals
8-day SMA
Sell
Level
$17.24
200-day SMA
Sell
Level
$18.55
Bollinger Bands (100)
Buy
Level
16.09 - 18.01
Chaikin Money Flow
Sell
Level
-4.3K
20-day SMA
Buy
Level
$17.11
Relative Strength Index (RSI14)
Buy
Level
50.87
ADX Line
Buy
Level
22.18
Williams %R
Neutral
Level
-39.485
50-day SMA
Sell
Level
$17.26
MACD (12, 26)
Buy
Level
4.78
25-day Aroon Oscillator
Sell
Level
-20
On Balance Volume
Neutral
Level
564.5K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.6783)
Sell
CA Score
(Annual)
Level (-0.4467)
Buy
Beneish M-Score
(Annual)
Level (-3.0736)
Buy
Momentum Score
Level (10)
Buy
Ohlson Score
Level (-0.4623)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Marcus Corp is engaged in two business segments, which are movie theatres and Hotels and Resorts. The movie theatres segment operates multiscreen motion picture theatres in Wisconsin, Illinois, Iowa, Minnesota, Missouri, Nebraska, North Dakota, Ohio and others, a family entertainment center in Wisconsin and a retail center in Missouri; Hotels and Resorts segment owns and operates full-service hotels and resorts in Wisconsin, Illinois, and Nebraska and manages full-service hotels, resorts and other properties in Wisconsin, Minnesota, Texas, Nevada, California, and North Carolina. It generates maximum revenue from the Theatres segment.
Stock Forecast FAQ
In the current month, MCS has received 3 Buy ratings 0 Hold ratings, and 0 Sell ratings. The MCS average analyst price target in the past 3 months is $24.67.
-
Where Will Marcus Stock Be In 1 Year?
According to analysts, the consensus estimate is that Marcus share price will rise to $24.67 per share over the next 12 months.
-
What Do Analysts Say About Marcus?
Analysts are divided on their view about Marcus share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Marcus is a Sell and believe this share price will drop from its current level to $24.00.
-
What Is Marcus's Price Target?
The price target for Marcus over the next 1-year time period is forecast to be $24.67 according to 3 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is MCS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Marcus is a Buy. 3 of 3 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of MCS?
You can purchase shares of Marcus via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Marcus shares.
-
What Is The Marcus Share Price Today?
Marcus was last trading at $17.24 per share. This represents the most recent stock quote for Marcus. Yesterday, Marcus closed at $17.24 per share.
-
How To Buy Marcus Stock Online?
In order to purchase Marcus stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
93
EXOD alert for Jul 18
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
